v3.25.4
Consolidated Statements of Equity - USD ($)
shares in Millions, $ in Millions
Total
Shareholders’ Equity [Member]
Common Stock [Member]
Add’l Paid-In Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Accum. Other Comp. Loss [Member]
Non-controlling Interests [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance, treasury (in shares)         (3,903)      
Beginning balance, common (in shares) at Dec. 31, 2022     9,519          
Beginning balance at Dec. 31, 2022 $ 95,916 $ 95,661 $ 476 $ 91,802 $ (113,969) $ 125,656 $ (8,304) $ 256
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 2,158 2,119       2,119   39
Other comprehensive income/(loss), net of tax 331 343         343 [1] (12)
Cash dividends declared:                
Common stock (9,316) (9,316)       (9,316)    
Noncontrolling interests (8)             (8)
Share-based payment transactions (in shares)     43   (12)      
Share-based payment transactions 208 208 $ 2 829 $ (518) (106)    
Other 0 0   0 $ 0 0   0
Ending balance, common (in shares) at Dec. 31, 2023     9,562          
Ending balance, treasury (in shares) at Dec. 31, 2023         (3,916)      
Ending balance at Dec. 31, 2023 89,288 89,014 $ 478 92,631 $ (114,487) 118,353 (7,961) 274
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance, treasury (in shares)         (3,916)      
Net income 8,062 8,031       8,031   31
Other comprehensive income/(loss), net of tax 116 118         118 [1] (3)
Cash dividends declared:                
Common stock (9,577) (9,577)       (9,577)    
Noncontrolling interests (7)             (7)
Share-based payment transactions (in shares)     31   (10)      
Share-based payment transactions 591 591 $ 2 972 $ (276) (107)    
Other $ 23 25   0   25   (1)
Ending balance, common (in shares) at Dec. 31, 2024 9,593   9,593          
Ending balance, treasury (in shares) at Dec. 31, 2024 (3,926)       (3,926)      
Ending balance at Dec. 31, 2024 $ 88,497 88,203 $ 480 93,603 $ (114,763) 116,725 (7,842) 294
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance, treasury (in shares) (3,926)       (3,926)      
Net income $ 7,812 7,771       7,771   41
Other comprehensive income/(loss), net of tax (239) (227)         (227) [1] (12)
Cash dividends declared:                
Common stock (9,779) (9,779)       (9,779)    
Noncontrolling interests (30)             (30)
Share-based payment transactions (in shares)     28   (10)      
Share-based payment transactions 509 509 $ 1 866 $ (251) (107)    
Other $ 6 (1)   0   (1)   6
Ending balance, common (in shares) at Dec. 31, 2025 9,621   9,621          
Ending balance, treasury (in shares) at Dec. 31, 2025 (3,935)       (3,935)      
Ending balance at Dec. 31, 2025 $ 86,775 $ 86,476 $ 481 $ 94,469 $ (115,015) $ 114,610 $ (8,069) $ 299
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance, treasury (in shares) (3,935)       (3,935)      
[1] Foreign currency translation adjustments include net gains/(losses) related to the impact of our net investment hedging program and gains/(losses) related to our previous investment in Haleon through third quarter of 2024, at which time we discontinued the application of the equity method to the Haleon investment (see Note 2C).